Bremelanotide PT141[Benefits |side effect | Usage |Reviews]

Bremelanotide ( PT – 141), began development in 2004 and is still undergoing trials. Bremelanotide is a peptide melanocortin receptor antagonist which is under current development by Palatin Technologies as the treatment for sexual dysfunction. It is made from the peptide Melanotan II, which underwent testing as a sunless tanning agent. In initial testing, it was ineffective as a tanning agent, however, it unexpectedly produced sexual arousal.

Bremelanotide PT141

Now also offer the PT-141 Pre Mixed Peptide Pen injection 10mg 3ml


M company Bremelanotide ( PT – 141) Sterility 100% , Purity 98% ,Assay in Solution 99%

Benefits & effect

Bremelanotide or PT-141 is a peptide used for the treatment of sexual duysfunction for men and women. Men can buy pt-141 online to dramatically increase sex drive, help induce erections, and improve overal erectile dysfunction. Women can purchase pt-141 for a powerful boost for sex drive and arousal. Bremelanotide (pt-141) is the first medication to be FDA approved for premenopausal women with Hypoactive Sexual Desire Disorder (HSDD); low sex drive. PT-141 is often used by women and men due to it’s effectiveness, because it can be used when desired within 45 minutes of anticipated sexual activity, and because there is no contraindication with alcohol use. Patients who buy bremalanotide (pt-141) from Ikon Health can be confident that they are receiving real PT-141 from a US pharmacy, with the required prescription.

side effect

While side effects are not likely to occur, some of the more common side effects include nausea and even less common side effects can include vomiting. If you experience these side effects contact your doctor.

Usage

A 2mg PT-141 dosage is generally effective for both men and women.

Description

Bremelanotide was developed from the peptide hormone Melanotan 2. In initial testing, Melanotan 2 did induce tanning but additionally caused sexual arousal and spontaneous erections as unexpected side effects in nine out of ten original male volunteer test subjects. (Ref: Uni of Arizona Dr Hunter Wells)

A full copy of all trials are available from Peptides Online. Please contact us for more information.

Protocol

  • Content and Potency: 10mg/mL x 2 mL vials ready-to-inject subcutaneous
  • Suggested dosage: Inject 0.2ml when required 4 hours prior to activity (Duration 6-8 hours).

Reviews